Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study. (2017)

First Author: Wedzicha JA

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2147/COPD.S125058

PubMed Identifier: 28176893

Publication URI: http://europepmc.org/abstract/MED/28176893

Type: Journal Article/Review

Volume: 12

Parent Publication: International journal of chronic obstructive pulmonary disease

ISSN: 1176-9106